Alphatec Holdings (ATEC) Net Cash Flow Growth (3y) (2013 - 2026)
Alphatec Holdings (ATEC) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | -48.90% |
| 10 | Alphatec Holdings | 1.35 Bn | 1.21 Bn | 136.48 Mn | -38.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.16% |
| Dec 31, 2025 | 30.68% |
| Sep 30, 2025 | -10.06% |
| Jun 30, 2025 | 27.77% |
| Mar 31, 2025 | 33.86% |
| Dec 31, 2024 | 53.69% |
| Sep 30, 2024 | -28.58% |
| Jun 30, 2024 | 27.87% |
| Mar 31, 2024 | -42.39% |
| Dec 31, 2023 | 2.22% |
| Sep 30, 2023 | 50.34% |
| Jun 30, 2023 | -83.76% |
| Mar 31, 2023 | 53.57% |
| Dec 31, 2022 | -27.60% |
| Sep 30, 2022 | -26.46% |
| Jun 30, 2022 | -182.29% |
| Mar 31, 2022 | -40.70% |
| Dec 31, 2021 | -79.55% |
| Sep 30, 2021 | 157.62% |
| Jun 30, 2021 | -249.42% |